ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,430Medicare Part D Prescriptions Filled, Including Refills

Rank: 27 out of 3734

$1.42M Total Retail Price of All Prescriptions

Rank: 24 out of 3734

819 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 819 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

7% of this provider’s 819 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 17,171 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 960 699 1 1
LISINOPRIL 793 607 2 3
LEVOTHYROXINE SODIUM 674 548 3 2
METOPROLOL TARTRATE 594 449 4 6
OMEPRAZOLE 534 390 5 4
AMLODIPINE BESYLATE 522 440 6 5
FUROSEMIDE 469 417 7 7
WARFARIN SODIUM 422 341 8 10
GABAPENTIN 401 246 9 17
METFORMIN HCL 398 303 10 8
METOPROLOL SUCCINATE 378 336 11 14
SERTRALINE HCL 317 307 12 18
HYDROCHLOROTHIAZIDE 304 222 13 9
CARVEDILOL 286 190 14 30
ZOLPIDEM TARTRATE 280 189 15 24
TRAMADOL HCL 273 214 16 20
OXYCODONE-ACETAMINOPHEN 249 127 S2 17 51
CITALOPRAM HBR 246 209 18 16
MIRTAZAPINE 246 215 18 45
TRAZODONE HCL 245 145 20 49
DONEPEZIL HCL 242 240 21 25
ATORVASTATIN CALCIUM 230 200 22 11
TAMSULOSIN HCL 219 176 23 29
CLOPIDOGREL 205 170 24 23
FENTANYL 190 109 S2 25 65
ATENOLOL 183 141 26 13
FAMOTIDINE 182 123 27 60
PRAVASTATIN SODIUM 181 137 28 15
QUETIAPINE FUMARATE 171 117 29 82
DIOVAN 169 142 30 31
BACLOFEN 167 68 31 142
CRESTOR 164 163 32 28
MELOXICAM 162 106 33 52
NAMENDA 161 161 34 44
BUSPIRONE HCL 161 120 34 129
RANITIDINE HCL 157 104 36 32
POTASSIUM CHLORIDE 148 138 37 19
JANUVIA 146 139 38 50
POLYETHYLENE GLYCOL 3350 145 128 39 53
METHYLPREDNISOLONE 145 108 39 133
VENLAFAXINE HCL ER 145 87 39 84
CYMBALTA 142 98 42 67
HYDROCODONE-ACETAMINOPHEN 141 61 S3 43 12
RISPERIDONE 139 108 44 62
PLAVIX 138 117 45 39
GLIMEPIRIDE 133 77 46 37
ADVAIR DISKUS 131 86 47 35
ALENDRONATE SODIUM 130 111 48 26
ABILIFY 125 57 49 159
DIGOXIN 123 103 50 43
ALLOPURINOL 119 94 51 33
FLUOXETINE HCL 116 79 52 61
ESCITALOPRAM OXALATE 115 81 53 68
LANTUS 114 71 54 54
LANTUS SOLOSTAR 114 59 54 102
RAMIPRIL 112 74 56 91
OLANZAPINE 112 66 56 106
FINASTERIDE 111 96 58 88
LEVETIRACETAM 110 68 59 105
SPIRIVA 110 75 59 40
IPRATROPIUM-ALBUTEROL 109 88 61 98
LOSARTAN POTASSIUM 106 87 62 21
PANTOPRAZOLE SODIUM 105 91 63 22
MORPHINE SULFATE ER 102 27 S2 64 104
OXYCODONE HCL 98 23 S2 65 58
METFORMIN HCL ER 97 73 66 66
PHENYTOIN SODIUM EXTENDED 93 42 67 149
ISOSORBIDE MONONITRATE ER 92 81 68 34
NEXIUM 91 50 69 36
EXELON 87 78 70 150
PAROXETINE HCL 86 30 71 59
PREDNISONE 86 73 71 42
CARBIDOPA-LEVODOPA 83 83 73 92
AZITHROMYCIN 81 59 74 38
FENOFIBRATE 80 63 75 81
GEMFIBROZIL 79 39 76 114
NOVOLOG 78 61 77 112
OXYBUTYNIN CHLORIDE ER 78 51 77 141
LISINOPRIL-HYDROCHLOROTHIAZIDE 76 58 79 27
CARISOPRODOL 75 15 R 80 134
IBUPROFEN 75 56 80 75
GLIPIZIDE 75 75 80 57
LIDODERM 72 51 83 170
FLUTICASONE PROPIONATE 72 58 83 46
BUMETANIDE 72 57 83 78
LATANOPROST 72 72 83 197
SULFAMETHOXAZOLE-TRIMETHOPRIM 71 52 87 117
LOVASTATIN 71 63 87 41
SPIRONOLACTONE 70 58 89 80
OXYCONTIN 68 0 S2 90 121
NYSTATIN 67 55 91 162
LYRICA 66 24 92 124
CLONIDINE HCL 65 35 93 79
CIPROFLOXACIN HCL 64 52 94 77
HUMALOG 64 39 94 146
SEROQUEL 62 43 96 161
VENTOLIN HFA 61 14 97 70
OXCARBAZEPINE 61 47 97 329
NIASPAN 61 42 97 125
METOCLOPRAMIDE HCL 60 26 100 158
ALBUTEROL SULFATE 58 52 101 128
LEVOFLOXACIN 57 49 102 116
VENLAFAXINE HCL 56 40 103 213
KLOR-CON M20 55 35 104 48
KLOR-CON M10 55 54 104 115
TRIAMCINOLONE ACETONIDE 55 41 104 131
AMLODIPINE BESYLATE-BENAZEPRIL 54 54 107 56
SYNTHROID 53 53 108 47
AMIODARONE HCL 53 41 108 203
PEN NEEDLE 53 34 108 152
TIZANIDINE HCL 53 13 108 245
DIVALPROEX SODIUM ER 51 12 112 198
OXYCODONE HCL-ACETAMINOPHEN 51 24 S2 112 122
AMITRIPTYLINE HCL 51 35 R 112 94
TIMOLOL MALEATE 51 43 112 359
CEPHALEXIN 50 35 116 120
DETROL LA 50 25 116 153
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.